This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Institut Claudius Regaud | |
|---|---|
| Name | Institut Claudius Regaud |
| Established | 1948 |
| Location | Toulouse, France |
| Type | Cancer research and treatment center |
| Affiliations | Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse |
Institut Claudius Regaud is a comprehensive cancer center located in Toulouse, France, integrating clinical oncology, radiotherapy, medical research, and multidisciplinary care. The center has historical ties to French oncology networks and associations, engages in national and international collaborations, and contributes to translational research and clinical trials. It operates within regional health frameworks and partners with universities, hospitals, research foundations, and industry consortia.
The origins of the center trace to post‑World War II developments in French oncology linked to figures such as Claudius Regaud, early radiobiology pioneers, and institutional reforms following the establishment of the Ministry of Health and reorganization of French hospital systems. Subsequent decades saw interactions with entities including the Institut Curie, Gustave Roussy, Centre Léon Bérard, and the Collège de France network while regional hospital restructuring connected it to the Centre hospitalier universitaire de Toulouse, CHU de Toulouse, and the Occitanie health region. Landmark developments overlapped with national initiatives such as the Plan Cancer and European programs influenced by the European Organisation for Research and Treatment of Cancer and regulatory frameworks like those shaped after the Helsinki Declaration for clinical research. Leadership and milestones involved collaborations with scientists affiliated with the Académie des sciences, clinicians from university hospitals, and policy interfaces with the Agence nationale de sécurité du médicament et des produits de santé.
The mission centers on integrated cancer care, translational research, and education in line with standards promoted by the World Health Organization, the European Commission, and national health authorities. Governance models reflect partnerships with the Institut Universitaire du Cancer, university faculties of Université Toulouse III — Paul Sabatier, hospital groups including the Assistance Publique – Hôpitaux de Paris framework in comparative context, and research bodies such as the Centre National de la Recherche Scientifique and Institut national de la santé et de la recherche médicale. Organizational units mirror structures found at the Comité de Coordination de la Recherche en Cancérologie and conform to accreditation practices advocated by international agencies like the International Agency for Research on Cancer.
Facilities encompass radiotherapy suites, medical oncology wards, surgical oncology theaters, pathology labs, and imaging centers comparable to those at Hôpital Européen Georges-Pompidou and Hôpital Saint-Louis. Departments include clinical oncology, radiobiology, pathology, nuclear medicine, medical imaging linked to European Society for Radiotherapy & Oncology standards, and supportive care services similar to offerings at Institut Gustave Roussy. Specialized units interface with departments in hematology, gastroenterology, and urology within the regional hospital network, and laboratory platforms collaborate with units of the Centre National de Recherche Scientifique and university research teams.
Research activities span basic radiobiology, translational oncology, immuno‑oncology, precision medicine, and clinical trials coordinated with networks such as the European Organization for Research and Treatment of Cancer, the National Institute for Health and Care Research analogues in Europe, and consortia modeled on collaborations with Institut Pasteur and Inserm. Innovation programs partner with biotechnology companies, startups from regional incubators, and European research initiatives funded through the Horizon 2020 and Horizon Europe frameworks. Investigations draw on techniques from genomics centers that interface with platforms like EMBL and bioinformatics groups linked to the Agence nationale de la recherche projects, while clinical trial protocols follow guidance aligned with the Good Clinical Practice standards and international ethics committees.
Clinical services deliver multidisciplinary tumor boards, outpatient chemotherapy, targeted therapy clinics, and stereotactic radiotherapy comparable to offerings at Peter MacCallum Cancer Centre and MD Anderson Cancer Center. Patient navigation coordinates with palliative care models established in collaboration with hospices and community providers, drawing on quality standards from organizations such as the Organisation for Economic Co-operation and Development health indicators. Supportive services include psycho‑oncology, social work liaising with regional social services, and survivorship programs informed by research from international centers including Memorial Sloan Kettering Cancer Center.
The center provides postgraduate training, residency rotations, and fellowship programs in partnership with Université Toulouse III — Paul Sabatier, medical schools, and professional societies such as the French Society of Radiation Oncology and European bodies like the Union for International Cancer Control. Continuing medical education events align with curricula of the European Society for Medical Oncology and collaborative workshops with research institutes including Institut Curie and Gustave Roussy.
Collaborations include clinical and research partnerships with regional university hospitals, national research organizations like Inserm and CNRS, European consortia funded under Horizon Europe, and industry collaborations with pharmaceutical firms and medical device manufacturers. International links extend to centers such as Institut Pasteur, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Karolinska Institutet, and networks including the European Reference Networks and European Organisation for Research and Treatment of Cancer to support multicenter trials, translational projects, and knowledge exchange.
Category:Cancer research institutes Category:Hospitals in Toulouse